Clinical Edge Journal Scan

Gastric cancer: Diagnostic accuracy of esophagogastroduodenoscopy depends on gastric observation time


 

Key clinical point: A shorter gastric observation time during index esophagogastroduodenoscopy (EGD; preceding gastric cancer diagnosis) serves as an important predictor of the occurrence of interval advanced gastric cancer.

Major finding: A shorter observation time (<3 min; adjusted odds ratio 2.27; 95% CI 1.20-4.30) at preceding endoscopy was independently associated with an increased risk for interval advanced gastric cancer.

Study details: Findings are from a retrospective nested case-control study that included 1257 patients diagnosed with gastric cancer within 6-36 months of “cancer-negative” index EGD, of which 102 patients had advanced gastric cancer.

Disclosures: This study was supported by the Research Fund of the Korean Society of Gastroenterology and a National Research Foundation of Korea grant funded by the Korea government. The authors declared no conflicts of interest.

Source: Kim TJ et al. Interval advanced gastric cancer after negative endoscopy. Clin Gastroenterol Hepatol. 2022 (Sep 5). Doi: 10.1016/j.cgh.2022.08.027

Recommended Reading

Refractory mCRC: Trifluridine/tipiracil plus bevacizumab effective and safe in real world
MDedge Hematology and Oncology
Coadministration of H2RA may not reduce efficacy of capecitabine in early CRC
MDedge Hematology and Oncology
Elevated pretreatment plasma PD-L1 level indicates worse prognosis in mCRC
MDedge Hematology and Oncology
Intraperitoneal paclitaxel+XELOX: A promising treatment option for gastric cancer peritoneal metastases
MDedge Hematology and Oncology
Surveillance endoscopy warranted in individuals at high risk for gastric cancer
MDedge Hematology and Oncology
Advanced gastric cancer: TMB status associated with first-line pembrolizumab therapy outcomes
MDedge Hematology and Oncology
Standard duration of S-1 or CAPOX adjuvant chemotherapy strongly recommended for GC treatment
MDedge Hematology and Oncology
Locally advanced gastric cancer: Lymph node ratio a prognosticator after neoadjuvant chemotherapy
MDedge Hematology and Oncology
Perioperative treatment and minimally invasive surgery improve outcomes in operable gastric cancer
MDedge Hematology and Oncology
Proximal and total gastrectomy with laparoscopy have similar outcomes in stage I gastric cancer
MDedge Hematology and Oncology